We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
+11.69%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.5B
AUM Growth
+$150M
Cap. Flow
+$15.1M
Cap. Flow %
1.01%
Top 10 Hldgs %
32.78%
Holding
318
New
24
Increased
38
Reduced
58
Closed
67

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$10M
2
AMZN icon
Amazon
AMZN
+$9.94M
3
MRVL icon
Marvell Technology
MRVL
+$9.73M
4
DOV icon
Dover
DOV
+$9.5M
5
PANW icon
Palo Alto Networks
PANW
+$9.27M

Top Sells

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$1.34M
2
JPM icon
JPMorgan Chase
JPM
+$1.33M
3
CI icon
Cigna
CI
+$1.23M
4
HON icon
Honeywell
HON
+$1.2M
5
PGR icon
Progressive
PGR
+$1.18M

Sector Composition

Rank Sector Weight
1 Technology 23.25%
2 Industrials 17.54%
3 Financials 12.92%
4 Healthcare 12.82%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSB icon
151
SouthState Bank Corp
SSB
$10.3B
$357K 0.02%
4,671
– –
APLS
152
DELISTED
Apellis Pharmaceuticals
APLS
$356K 0.02%
6,892
– –
TMHC
153
DELISTED
Taylor Morrison
TMHC
$354K 0.02%
11,680
– –
TD icon
154
Toronto Dominion Bank
TD
$199B
$354K 0.02%
5,467
-4,552
-45% -$294K
SLAB icon
155
Silicon Laboratories
SLAB
$7.29B
$353K 0.02%
2,605
+489
+23% +$64.3K
SWN
156
DELISTED
Southwestern Energy Company
SWN
$350K 0.02%
59,864
+4,140
+7% +$27.2K
WERN icon
157
Werner Enterprises
WERN
$2.3B
$348K 0.02%
8,635
– –
TVTX icon
158
Travere Therapeutics
TVTX
$6.19B
$347K 0.02%
16,487
+1,989
+14% +$42.1K
VTRS icon
159
Viatris
VTRS
$18.8B
$345K 0.02%
31,019
– –
AMRC icon
160
Ameresco
AMRC
$1.17B
$345K 0.02%
6,037
– –
UCB
161
United Community Banks
UCB
$4.24B
$339K 0.02%
10,043
– –
SR icon
162
Spire
SR
$4.88B
$338K 0.02%
4,903
– –
MYRG icon
163
MYR Group
MYRG
$4.58B
$337K 0.02%
3,663
-814
-18% -$73.9K
FOLD
164
DELISTED
Amicus Therapeutics
FOLD
$334K 0.02%
27,361
– –
IRT icon
165
Independence Realty Trust
IRT
$3.84B
$333K 0.02%
+19,777
New +$335K
FXI icon
166
iShares China Large-Cap ETF
FXI
$4.23B
$333K 0.02%
+11,759
New +$304K
NGG icon
167
National Grid
NGG
$79.8B
$330K 0.02%
5,813
+736
+14% +$39.3K
CNMD icon
168
CONMED
CNMD
$1.5B
$327K 0.02%
3,689
+666
+22% +$55.3K
NMIH icon
169
NMI Holdings
NMIH
$3.37B
$326K 0.02%
15,594
+1,786
+13% +$37.4K
ABM icon
170
ABM Industries
ABM
$2.77B
$326K 0.02%
7,336
– –
MXL icon
171
MaxLinear
MXL
$5.6B
$317K 0.02%
9,351
+930
+11% +$31.5K
KAI icon
172
Kadant
KAI
$3.57B
$316K 0.02%
1,780
– –
ESNT icon
173
Essent Group
ESNT
$6.19B
$306K 0.02%
7,874
– –
FOCS
174
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$306K 0.02%
+8,212
New +$292K
AZN icon
175
AstraZeneca
AZN
$252B
$305K 0.02%
2,251
-3,698
-62% -$464K
5 6
7
8 9

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Henshaw Capital held 318 positions worth $1.5B, up 11% from $1.35B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Henshaw Capital's Q4 2022 filing shows 24 new, 38 increased, 58 reduced and 67 closed positions. Its largest new stake was Marvell Technology: 238,382 shares worth $8.83M. The largest sale was Ulta Beauty, an estimated $1.34M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Financials.

  • Henshaw Capital's largest Q4 2022 buy was Marvell Technology: 238,382 shares worth $8.83M.
  • Henshaw Capital added most to CVS Health in Q4 2022, an estimated $10M increase.
  • Henshaw Capital's biggest Q4 2022 reduction was Ulta Beauty, cutting an estimated $1.34M.
  • Henshaw Capital fully exited Cigna in Q4 2022, selling an estimated $1.23M.
  • Henshaw Capital's ten largest holdings make up 33% of its $1.5B portfolio in Q4 2022.
  • Henshaw Capital opened 24 new positions and closed 67 in Q4 2022.
  • Henshaw Capital's portfolio value rose 11% quarter-over-quarter to $1.5B.

Based on Henshaw Capital's 13F filing for Q4 2022, filed 28 May 2026.